High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes
NCT07118670
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Proliferative Diabetic Retinopathy (PDR)
Interventions
DRUG:
Aflibercept 8mg
Sponsor
Edward Wood, MD
Collaborators
Greater Houston Retina Research